Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 264-980-3 | CAS number: 64628-44-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1979
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- significant methodological deficiencies
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 979
- Report date:
- 1979
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- - Principle of test: To determine the sub-acute inhilation toxicity of the test substance to rats, over a series of experimental phases designed to represent short-term inhilation exposure.
- Short description of test conditions: Male and female rats were exposed daily for 6 hours, 15 times over 3 weeks in three test series (I), (II), (III), to the following concentrations (analytically determined) of triflumuron, present as an easily respirable aerosol in the breathing air of the animals:
control groupS:
(I) and (II): 0 mg/kg m3 air
(III): 20000 µL DMS/Lutrol/m3 air
concentration groups:
(I) 1: 9 mg Triflumuron/m3 air
(I) 2: 29 mg Triflumuron/m3 air
(I) 3: 92 mg Triflumuron/m3 air
(II) 1: 3 mg Triflumuron/m3 air
(II) 2: 8 mg Triflumuron/m3 air
(III) 1: 9.3 mg Triflumuron/m3 air
(III) 2: 94.3 mg Triflumuron/m3 air.
For technical reasons Triflumuron was formulated in a mixture of DMSO/Lutrol (1:1). Laboratory examinations were performed at the end of the experiment. At sacrifice, gross findings were recorded and organs weighed. A number of organs were examined histopathologically. - GLP compliance:
- no
- Remarks:
- Study conducted pre-GLP
Test material
- Reference substance name:
- 2-chloro-N-[[[4-(trifluoromethoxy)phenyl]amino]carbonyl]benzamide
- EC Number:
- 264-980-3
- EC Name:
- 2-chloro-N-[[[4-(trifluoromethoxy)phenyl]amino]carbonyl]benzamide
- Cas Number:
- 64628-44-0
- Molecular formula:
- C15H10ClF3N2O3
- IUPAC Name:
- 3-(2-chlorobenzoyl)-1-[4-(trifluoromethoxy)phenyl]urea
- Test material form:
- not specified
1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- TNO/W 74 albino
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Rats were approx. 160-170g (females) or 180-220g (males) body weight at start of study. The rats were kept conventionally in Makrolon® cages, type III (5 animals/cage; markings: cage numbering and color markings). The animal room was illuminated daily from 7.00 to 19.00 h. The room temperature was approx. 21°C with the climate regulated by air conditioning. The animals were kept on a standard pre-prepared diet specific to the species (Altromin R) and water ad libitum.
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- not specified
- Vehicle:
- other: The test article was formulated in various concentrations with DMSO and Lutrol (1:1)
- Remarks on MMAD:
- Distribution of particle size per concentration was determined once in the second test week and once at the end of the exposure. This was performed using a cascade impactor. After photographic presentation by microscope, the particles were compared by measuring with a micrometer, and their diameter converted (only test series III were determined) .
- Details on inhalation exposure:
- Male and female rats were exposed daily for 6 hours, 15 times over 3 weeks in three test series (I), (II), (III), to the following concentrations (analytically determined) of triflumuron, present as an easily respirable aerosol in the breathing air of the animals.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Cotton wool was used to adsorb the active ingredient from the inhalation air. The active ingredient was then quantitatively eluted with absolute ethanol. Determination of the active ingredient was made spectrophotometrically at 250 nm at a path length of 1 cm.
- Duration of treatment / exposure:
- exposed daily for six hours, 15 times over 3 weeks
- Frequency of treatment:
- daily
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/m³ air
- Remarks:
- control series I and II
- Dose / conc.:
- 20 000 other: µL DMS/Lutrol/m3 air
- Remarks:
- control series III (vehicle control only)
- Dose / conc.:
- 9 mg/m³ air
- Remarks:
- test concentration series I (group 1)
- Dose / conc.:
- 29 mg/m³ air
- Remarks:
- test concentration series I (group 2)
- Dose / conc.:
- 92 mg/m³ air
- Remarks:
- test concentration series I (group 3)
- Dose / conc.:
- 3 mg/m³ air
- Remarks:
- test concentration series II (group 1)
- Dose / conc.:
- 8 mg/m³ air
- Remarks:
- test concentration series II (group 2)
- Dose / conc.:
- 9.3 mg/m³ air
- Remarks:
- test concentration series III (group 1)
- Dose / conc.:
- 94.3 mg/m³ air
- Remarks:
- test concentration series III (group 2)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- Triflumuron was sprayed dynamically. The tests were performed in a dynamic inhalation apparatus. For technical reasons the test article was formulated in various concentrations with DMSO/Lutrol (1:1) (dimethylsulfoxide - polyethylene glycol 400) and then nebulized dynamically into the inhalation chamber. It was not possible to formulate the test article with ethanol/Lutrol. The animals were exposed so that they could only inhale the aerosol with the breathing air. The aerosols did not come into contact with the skin. Three series of tests were performed in order to determine the concentration tolerated without lesions occurring.
Examinations
- Observations and examinations performed and frequency:
- The appearance and behavior of the animals were assessed daily during the study period. The body weights of the animals were determined before the start of the test and then at the end of each week (test series I, II and III).
- Sacrifice and pathology:
- 24 hours after the end of the treatment the rats were subjected to necropsy under ether anaesthetic. The rats were killed by desanguination (heart puncture). The internal organs were grossly assessed. Following this the following organs were weighed: thyroid, heart, lung, liver, spleen, kidneys, adrenal, testes and ovaries.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Only in test series I, behavioural disorders and pre-terminal deaths occurred. These findings were not
reproducible in test series II or III where the same conditions prevailed. - Mortality:
- mortality observed, treatment-related
- Description (incidence):
- In test series I the following rats died:
One female rat from the control group after 5th exposure
Three female rats from the highest concentration group 92 mg/m3 air after the 2nd, 3rd and 4th exposure.
In test series II the following rats died:
One female rat from the concentration group 3 mg/m3 air in the night following the 4th exposure.
There were no mortalities in test series III. - Body weight and weight changes:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Only in test series I, a short-term reversible loss of weight was seen. These findings were not reproducible in test series II or III where the same conditions prevailed.
- Haematological findings:
- no effects observed
- Description (incidence and severity):
- No significant variation from the norm and no group-specific deviations were observed.
- Clinical biochemistry findings:
- no effects observed
- Description (incidence and severity):
- No significant variation from the norm and no group-specific deviations were observed.
- Urinalysis findings:
- no effects observed
- Description (incidence and severity):
- No significant variation from the norm and no group-specific deviations were observed.
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Description (incidence and severity):
- No treatment-related organ weight changes.
- Gross pathological findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Only in test series there was a histological evidence of inflammatory changes to the respiratory tract. These findings were not reproducible in test series II or III and were thus considered incidental findings.
Effect levels
- Key result
- Dose descriptor:
- NOAEC
- Effect level:
- > 94.3 mg/m³ air
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- other: Tested up to the maximum producible concentration
Target system / organ toxicity
- Key result
- Critical effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- No-observed-effect-level (NOEL) : 94.3 mg/m3 air (the maximum producible concentration).
- Executive summary:
Male and female rats were exposed daily for 6 hours, 15 times over 3 weeks in three test series to concentrations (analytically determined) of triflumuron, present as an easily respirable aerosol in the breathing air of the animals. For technical reasons, the test material was formulated in a mixture of DMSO/Lutrol (1:1). Exposure groups were 0 (controls), 9, 29, 92, 3, 8, 9.3 and 94.3 mg/m3 air. The DMSO formulation vehicle revealed clear histological evidence of inflammatory changes to the respiratory tract, particularly amongst the female rats. This led to behavioural disorders, short-term reversible loss of weight and mortalities amongst the animals in the initial test series; however, these clinical findings were not confirmed in subsequent test series using the same test conditions prevailed. Haematological, clinical chemistry and urine examinations, as well as determination of organ weight revealed no evidence of lesions in all the animals. There was no additional histopathological evidence of lesions occurring in all animals. Treatment with triflumuron at a concentrations up to 94.3 mg/m3 air at 15 x 6 hour exposure over 3 weeks produced no lesions in male or female rats. 94.3 mg/m3 air was the maximum producible concentration.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.